Literature DB >> 8258942

[A case report: reversible male infertility due to congenital adrenal hyperplasia].

T Iwamoto1, M Yajima, H Tanaka, N Minagawa, T Osada.   

Abstract

We have studied a 32-year-old patient who was infertile because of azoospermia, We made the final diagnosis of non-classical congenital adrenal hyperplasia (CAH) caused by 21-hydroxylase deficiency with adrenal rest tumor of bilateral testes and bilateral adrenal myelolipoma. The patient was given 1.5 mg/day dexamethasone. Decreases in the levels of 17 OHP and adrenal androgen were rapidly observed. After 5 months of treatment, semen analysis showed a sperm density of 2 x 10(4)/ml with 50% motile spermatozoa. His wife became pregnant and delivered of a healthy daughter. We conclude that chronic suppression of gonadotropins secretion caused by overproduction of adrenal androgens in CAH would appear to be the cause for the failure of testicular development and spermatogenesis.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8258942     DOI: 10.5980/jpnjurol1989.84.2031

Source DB:  PubMed          Journal:  Nihon Hinyokika Gakkai Zasshi        ISSN: 0021-5287


  3 in total

1.  Genotyping of congenital adrenal hyperplasia due to 21-hydroxylase deficiency presenting as male infertility: case report and literature review.

Authors:  Y Sugino; T Usui; K Okubo; K Nagahama; T Takahashi; H Okuno; H Hatayama; O Ogawa; A Shimatsu; H Nishiyama
Journal:  J Assist Reprod Genet       Date:  2006-10-11       Impact factor: 3.412

2.  Lack of ACTH and androgen receptor expression in a giant adrenal myelolipoma associated with 21-hydroxylase deficiency.

Authors:  Hanae Hagiwara; Takeshi Usui; Takashi Kimura; Tetsuya Tagami; Mitsuhide Naruse; Sachiko Minamiguchi; Takuma Kato; Hiroshi Okuno; Akira Shimatsu
Journal:  Endocr Pathol       Date:  2008       Impact factor: 3.943

Review 3.  Medical management of non-obstructive azoospermia.

Authors:  Rajeev Kumar
Journal:  Clinics (Sao Paulo)       Date:  2013       Impact factor: 2.365

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.